4.0 Article

Case Report of a Novel Association between Anti-p200 Pemphigoid and Acquired Haemophilia A

Journal

ANNALS OF DERMATOLOGY
Volume 35, Issue 1, Pages 61-65

Publisher

KOREAN DERMATOLOGICAL ASSOC
DOI: 10.5021/ad.20.301

Keywords

Blister; Dermatoses; Factor VIII; Hemophilia; Pemphigoid

Categories

Ask authors/readers for more resources

Anti-p200 pemphigoid is a rare subepidermal autoimmune bullous disease that has not been previously associated with hematological diseases. In this case report, a patient with acquired hemophilia A was diagnosed with anti-p200 pemphigoid, highlighting the importance of recognizing the potential association between these two conditions.
Anti-p200 pemphigoid is an uncommon subepidermal autoimmune bullous disease that, unlike many other autoimmune bullous diseases, has not previously been associated with hematological diseases. The diagnosis of anti-p200 pemphigoid in a patient with congruent clinical features requires the demonstration of subepidermal blistering, with linear deposition of immunoglobulin (Ig) G and/or C3 at the dermoepidermal junction on direct immunofluorescence, and a floor-binding pattern on indirect immunofluorescence. In addition, the detection of antibodies against p200 antigen via immunoblotting is ideal but not readily accessible in many facilities, leading to a potential under-recognition and under-diagnosis of this condition. In this case report, we describe a 53-year-old gentleman with recently diagnosed acquired hemophilia A who developed a concurrent vesiculobullous eruption and was evaluated to have anti-p200 pemphigoid. Both of his conditions were controlled with immunosuppression via prednisolone and cyclophosphamide. While we acknowledge the contemporaneous occurrence of both diseases in this patient may be a mere coincidence, it is important to recognize the possibility of this association given the potential clinical significance. Whether the activity of one disease parallels the other will require further evaluation.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.0
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Letter Dermatology

Rethinking the female predominance in hidradenitis suppurativa

Ellie Choi, Nisha S. Chandran

INTERNATIONAL JOURNAL OF DERMATOLOGY (2019)

Letter Dermatology

Impetigo as an adverse effect of topical 5% imiquimod treatment for viral warts

Li Wei Heng, Nisha S. Chandran

INTERNATIONAL JOURNAL OF DERMATOLOGY (2021)

Letter Dermatology

Three cases of vesiculobullous non-IgE-mediated cutaneous reactions to tozinameran (Pfizer-BioNTech COVID-19 vaccine)

L. Juay, N. S. Chandran

JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2021)

Letter Dermatology

Natural Occurrence of Autoantibodies against Basement Membrane Proteins in Epidermolysis Bullosa

Antoni Gostynski, Gilles F. H. Diercks, Maria-Jose Escamez, Nisha Suyien Chandran, Raul de Lucas, Adela Garcia-Martin, Marcela Del Rio, Jeroen Bremer, Maria C. Bolling, Alvaro Meana, Sara G. Llames, Enno Schmidt, Ralf Ludwig, Marcel F. Jonkman, Hendri H. Pas, Anna M. G. Pasmooij

JOURNAL OF INVESTIGATIVE DERMATOLOGY (2022)

Letter Dermatology

Trichostasis Spinulosa as Manifestation of Cutaneous Graft versus Host Disease

Jiekai Tan, Jingxiang Huang, Nisha Suyien Chandran

ANNALS OF DERMATOLOGY (2020)

No Data Available